Research analysts at KeyCorp began coverage on shares of ICU Medical, Inc. (NASDAQ:ICUI) in a research report issued to clients and investors on Tuesday. The brokerage set a “sector weight” rating on the medical instruments supplier’s stock.

Several other research firms also recently commented on ICUI. Zacks Investment Research upgraded shares of ICU Medical from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th. Sidoti downgraded shares of ICU Medical from a “buy” rating to a “neutral” rating in a research note on Tuesday, June 20th. BidaskClub downgraded shares of ICU Medical from a “hold” rating to a “sell” rating in a research note on Wednesday, August 9th. Finally, Gabelli restated a “buy” rating on shares of ICU Medical in a research note on Friday, August 11th. One analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. ICU Medical currently has an average rating of “Hold” and an average target price of $193.00.

ICU Medical (ICUI) traded up 0.37% during trading on Tuesday, hitting $189.35. 3,684 shares of the stock were exchanged. The stock has a market capitalization of $3.75 billion, a price-to-earnings ratio of 75.83 and a beta of 0.35. The firm has a 50-day moving average of $183.43 and a 200-day moving average of $169.40. ICU Medical has a 52 week low of $127.00 and a 52 week high of $192.65.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.58 by ($0.06). ICU Medical had a net margin of 6.10% and a return on equity of 7.56%. The business had revenue of $331.51 million during the quarter, compared to analyst estimates of $318.30 million. During the same quarter last year, the company posted $1.15 earnings per share. The company’s revenue was up 242.8% on a year-over-year basis. Equities research analysts anticipate that ICU Medical will post $4.11 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “ICU Medical, Inc. (ICUI) Now Covered by KeyCorp” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/10/19/icu-medical-inc-icui-now-covered-by-keycorp.html.

In related news, Director Joseph R. Saucedo sold 9,000 shares of the company’s stock in a transaction dated Monday, October 9th. The shares were sold at an average price of $189.46, for a total transaction of $1,705,140.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Vivek Jain sold 2,200 shares of the company’s stock in a transaction dated Monday, October 9th. The stock was sold at an average price of $190.91, for a total transaction of $420,002.00. Following the sale, the chief executive officer now directly owns 44,111 shares of the company’s stock, valued at approximately $8,421,231.01. The disclosure for this sale can be found here. Insiders have sold 22,452 shares of company stock valued at $4,127,838 in the last ninety days. 13.60% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of ICUI. First Trust Advisors LP lifted its position in ICU Medical by 42.0% during the first quarter. First Trust Advisors LP now owns 10,188 shares of the medical instruments supplier’s stock worth $1,556,000 after purchasing an additional 3,013 shares during the period. Parametric Portfolio Associates LLC lifted its position in ICU Medical by 10.1% during the first quarter. Parametric Portfolio Associates LLC now owns 26,715 shares of the medical instruments supplier’s stock worth $4,079,000 after purchasing an additional 2,459 shares during the period. Neuberger Berman Group LLC lifted its position in ICU Medical by 37.7% during the first quarter. Neuberger Berman Group LLC now owns 1,915 shares of the medical instruments supplier’s stock worth $292,000 after purchasing an additional 524 shares during the period. Municipal Employees Retirement System of Michigan lifted its position in ICU Medical by 1.2% during the first quarter. Municipal Employees Retirement System of Michigan now owns 3,360 shares of the medical instruments supplier’s stock worth $513,000 after purchasing an additional 40 shares during the period. Finally, Legal & General Group Plc lifted its position in ICU Medical by 2.3% during the first quarter. Legal & General Group Plc now owns 26,185 shares of the medical instruments supplier’s stock worth $3,998,000 after purchasing an additional 592 shares during the period. 78.13% of the stock is owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Receive News & Stock Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related stocks with our FREE daily email newsletter.